CIK 0001808805 · Non-accelerated filer<br>Smaller reporting company
Nautilus Biotechnology, Inc.
Sign in to watch- Ticker
- NAUT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981541723
- Phone
- 206-333-2001
- Business address
- 2701 EASTLAKE AVE EAST, SEATTLE, WA, 98102
- Former names
- ARYA Sciences Acquisition Corp III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-17 | Godwin Mary E. Senior VP, Operations | Option exercise | +35,000 | $0.46 | $16K | 35,000 |
| 2024-09-17 | Godwin Mary E. Senior VP, Operations | Sale | −35,000 | $2.85 | $100K | 0 |
| 2024-09-17 | Godwin Mary E. Senior VP, Operations | Option exercise · Stock Option (Right to Buy) | −35,000 | 400,368 | ||
| 2024-09-16 | Suzuki Kentaro Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2024-06-14 | McIlwain Matthew S Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-06-14 | Akinsanya Karen Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-06-14 | Epperly Melissa B, Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-06-14 | Pande Vijay Satyanand Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-06-14 | NAZEM FARZAD Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-06-14 | Posard Matthew L. Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-06-14 | ALTMAN MICHAEL SETH Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-06-14 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2024-03-11 | Patel Sujal M CEO, President, and Secretary | Purchase | +12,044 | $2.84 | $34K | 10,064,488 |
| 2024-03-08 | Patel Sujal M CEO, President, and Secretary | Purchase | +2,430 | $2.99 | $7K | 10,052,444 |
| 2024-03-07 | Patel Sujal M CEO, President, and Secretary | Purchase | +18,854 | $2.89 | $54K | 10,050,014 |
| 2024-03-06 | Patel Sujal M CEO, President, and Secretary | Purchase | +9,267 | $2.70 | $25K | 10,031,160 |
| 2024-03-05 | Patel Sujal M CEO, President, and Secretary | Purchase | +7,405 | $2.65 | $20K | 10,021,893 |
| 2024-03-01 | Patel Sujal M CEO, President, and Secretary | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2024-03-01 | Mallick Parag Chief Scientist | Grant or award · Stock Option (Right to Buy) | +280,000 | 280,000 | ||
| 2024-03-01 | Nelson Nicholas A. CBO & Senior VP, Bus. Dev. | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 |
Page 3 of 8 · 144 trades